Kindly MD Delays 10-Q Filing Amid Merger Complexity

Kindly MD ( (NAKA) ) has released a notification of late filing.

Meet Your ETF AI Analyst

• Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
• Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

Kindly MD, Inc., a Utah-based company, has filed a Form 12b-25 to notify the delay of its Form 10-Q (Quarter Report) for the period ending September 30, 2025. The primary reason for the delay is the complexity of accounting related to a recent merger with Nakamoto Holdings, Inc., which requires additional time to ensure compliance with U.S. GAAP and PCAOB standards. The company anticipates filing the delayed report within the 5-day extension period allowed by the SEC. Preliminary financial results indicate significant changes, including realized and unrealized losses on digital assets and a substantial loss on the acquisition of Nakamoto. These figures are subject to change upon completion of the quarter-end review. The company remains committed to compliance and transparency, as evidenced by the notification signed by CEO David Bailey.

The most recent analyst rating on (NAKA) stock is a Sell with a $0.50 price target. To see the full list of analyst forecasts on Kindly MD stock, see the NAKA Stock Forecast page.

Spark’s Take on NAKA Stock

According to Spark, TipRanks’ AI Analyst, NAKA is a Underperform.

The overall stock score of 38 reflects significant financial and technical challenges. The company’s financial performance is weak, with declining revenues and profitability issues. Technical analysis indicates bearish momentum, and valuation metrics are unattractive due to negative earnings. These factors collectively contribute to a low stock score.

To see Spark’s full report on NAKA stock, click here.

More about Kindly MD

Average Trading Volume: 23,416,955

Technical Sentiment Signal: Sell